Insider Transactions in Q2 2025 at Genprex, Inc. (GNPX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Ryan M. Confer President, CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,775
-14.91%
|
$0
$0.23 P/Share
|
|
Jun 30
2025
|
Mark Stanley Berger Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,500
-20.03%
|
$0
$0.23 P/Share
|